Global Genetic Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Genetic Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Others, and Predictive and Presymptomatic Testing), Technology (Cytogenetic testing, Biochemical testing, and Molecular testing), Application (Cancer diagnosis, Genetic Technology diagnosis, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Genetic Testing Market was valued at USD 17,840.3 million in 2023 and is expected to reach USD 40,233.1 million by 2031 while growing at a CAGR of 10.7% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global genetic testing market growth. Genetic testing analyzes an individual's DNA, chromosomes, or proteins to identify changes associated with genetic disorders, inherited conditions, or Technology predisposition. These tests offer valuable insights into Technology risk, medication response, and ancestry based on a person's genetic makeup.
Continuous advancements in genomic technologies, such as next-generation sequencing (NGS), microarray analysis, and polymerase chain reaction (PCR), coupled with the increasing prevalence of genetic disorders, drive the genetic testing market. However, challenges related to cost and affordability, along with ethical, legal, and social concerns, hinder market growth.
Furthermore, the global genetic testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Genetic Testing Market is segmented among Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Others, and Predictive and Presymptomatic Testing, based on Type. In 2023, Prenatal and Newborn Testing accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Technology Analysis
The Global Genetic Testing Market is segmented among Cytogenetic testing, Biochemical testing, and Molecular testing, based on Technology. In 2023, Molecular testing accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Genetic Testing Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are F. Hoffmann-La Roche Ltd., Luminex Corporation, Bio-Rad Laboratories, Inc., Illumina, Inc., Danaher Corporation, CSL Limited, Thermo Fisher Scientific, Inc., Abbott Laboratories, Myriad Genetics, Inc., and Qiagen N.V.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Genetic Testing Market Dynamics
Drivers
Restraints
Opportunity
4. Global Genetic Testing Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Genetic Testing Market Segmentation, By Type
Global Genetic Testing Market Share Analysis, By Type
Global Genetic Testing Market Growth Analysis, By Type
Global Genetic Testing Market Trends, By Type
o Carrier Testing
o Prenatal and Newborn Testing
o Diagnostic Testing
o Pharmacogenomic Testing
o Others
o Predictive and Presymptomatic Testing
6. Global Genetic Testing Market Segmentation, By Technology
Global Genetic Testing Market Share Analysis, By Technology
Global Genetic Testing Market Growth Analysis, By Technology
Global Genetic Testing Market Trends, By Technology
o Cytogenetic testing
o Biochemical testing
o Molecular testing
7. Global Genetic Testing Market Segmentation, By Application
Global Genetic Testing Market Share Analysis, By Application
Global Genetic Testing Market Growth Analysis, By Application
Global Genetic Testing Market Trends, By Application
o Cancer diagnosis
o Genetic disease diagnosis
o Others
8. Global Genetic Testing Market Segmentation, By Region
Global Genetic Testing Market Share Analysis, By Region
Global Genetic Testing Market Growth Analysis, By Region
Global Genetic Testing Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
F. Hoffmann-La Roche Ltd.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Luminex Corporation
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Danaher Corporation
CSL Limited
Thermo Fisher Scientific, Inc.
Abbott Laboratories
Myriad Genetics, Inc.
Qiagen N.V.
*Similar analysis will be provided for each company listed above.
